Genezen | BiotechTV

top of page

BIO International 2025: CEO Steve Favaloro introduces us to Genezen - a best-in-class CDMO with a preclinical to commercial offering

From the floor of the BIO International Convention, he describes the services that Genezen offers, its growth, and how it can partner...

Company News

Jun 16

Genezen's CEO discusses the current supply situation in viral vector manufacturing

Steve Favaloro explains why the industry is seeing shortages and what is being done by companies to boost supply.

Bright Minds

Oct 19, 2023

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.

Learn more about Genezen

bottom of page

BIO International 2025: CEO Steve Favaloro introduces us to Genezen - a best-in-class CDMO with a preclinical to commercial offering

Genezen's CEO discusses the current supply situation in viral vector manufacturing

Follow BiotechTV

Sponsors

Sponsor Spotlight